-
-
-
-
-
-
-
Abbvie (ABBV) Reiterated at Overweight by Cantor Fitzgerald after Analyst Call
-
-
-
-
-
-
-
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
-
-
-
-
-
-
-
Revolution Medicines stock rises on Merck acquisition talks
-
-
-
-
-
-
-
Enveric Biosciences hires Fish & Richardson to defend patent tied to AbbVie deal
-
-
-
-
-
-
-
AbbVie sees no outsized tariff exposure, boosts profit forecast
-
-
-
-
-
-
-
Sanofi to acquire Vigil Neuroscience in Alzheimer’s drug play
-
-
-
-
-
-
-
AbbVie (ABBV) Completes Acquisition of Nimble Therapeutics
-
1,173,814 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

